Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Virchows Archiv : an International Journal of Pathology
|
October 10, 2025
ALK-Rearranged renal neoplasms: update on an institutional cohort
Daniel Arizpe, Alexander J Gallan, Adam M Kase, et al.
Cancers
|
August 12, 2023
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth
Sanjeev Shukla, Carlos Riveros, Mohammed Al-Toubat, et al.
The Review of Scientific Instruments
|
March 3, 2010
First results from the new RIKEN superconducting electron cyclotron resonance ion source (invited)
T Nakagawa, Y Higurashi, J Ohnishi, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
Cancers
|
September 27, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing
Miguel Muniz, L Jill Tsai, Jacob J Orme, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617
Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
European Urology Oncology
|
August 2, 2025
Outcomes for [<sup>177</sup>Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer
Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
Cancer Treatment Reviews
|
May 4, 2024
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going
Miguel Muniz, Charles L Loprinzi, Jacob J Orme, et al.
Clinical Genitourinary Cancer
|
April 17, 2026
LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Jabra Zarka, Ronit Juthani, Oliver Sartor, et al.
Molecular Cancer Therapeutics
|
March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer
Adam M Kase, Justyna Gleba, James L Miller, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Virchows Archiv : an International Journal of Pathology
|
October 10, 2025
ALK-Rearranged renal neoplasms: update on an institutional cohort
Daniel Arizpe, Alexander J Gallan, Adam M Kase, et al.
Cancers
|
August 12, 2023
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth
Sanjeev Shukla, Carlos Riveros, Mohammed Al-Toubat, et al.
The Review of Scientific Instruments
|
March 3, 2010
First results from the new RIKEN superconducting electron cyclotron resonance ion source (invited)
T Nakagawa, Y Higurashi, J Ohnishi, et al.
Annals of Translational Medicine
|
July 21, 2025
Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy
Miguel Muniz, Daniel S Childs, Jack Andrews, et al.
Cancers
|
September 27, 2025
Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing
Miguel Muniz, L Jill Tsai, Jacob J Orme, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [<sup>177</sup>Lu]Lu-PSMA-617
Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
European Urology Oncology
|
August 2, 2025
Outcomes for [<sup>177</sup>Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer
Miguel Muniz, Oliver Sartor, Jacob J Orme, et al.
Cancer Treatment Reviews
|
May 4, 2024
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going
Miguel Muniz, Charles L Loprinzi, Jacob J Orme, et al.
Clinical Genitourinary Cancer
|
April 17, 2026
LuRa: Efficacy and Safety of Radium-223 Following [<sup>177</sup>Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Jabra Zarka, Ronit Juthani, Oliver Sartor, et al.
Molecular Cancer Therapeutics
|
March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer
Adam M Kase, Justyna Gleba, James L Miller, et al.
Page
of 15